Here’s why your health insurer is sounding more like RFK Jr.

Insurers are embracing the health secretary’s Make America Healthy Again movement as the GOP looks to cut health care costs.

New ACIP charter could allow RFK Jr. to further restrict vaccine access, critics say

Physician Self-Insurance Cooperative Plan

Strategic Blueprint for a Nationwide Physician-Owned Self-Insured Cooperative Introduction to the Physician-Owned Cooperative Paradigm The American healthcare system is currently defined by a high degree of centralization and corporatization, wherein managed care organizations, massive commercial...

Hundreds of Physicians, Other Clinicians at Banner Health File to Unionize

Concerns raised about patient panel sizes, staffing levels, scheduling practices

Is AI ruining our skills? Early results are in — and they’re not good

Reliance on artificial-intelligence tools degrades the abilities of physicians and software engineers, studies show.

Towards Conversational AI for Disease Management - Nature

While large language models (LLMs) have shown promise in diagnostic dialogue1, their capabilities for effective management reasoning—including disease progression, therapeutic response, and safe medication prescription—remain under-explored. We advance the previously demonstrated diagnostic capabilities of the Articulate Medical Intelligence Explorer (AMIE)1−3 through a new LLM-based agentic system optimized for multi-visit clinical management and dialogue. To ground its reasoning in authoritative clinical knowledge, AMIE leverages Gemini’s long-context capabilities4, combining in-context retrieval with structured reasoning to align its output with up-to-date clinical practice guidelines and drug formularies. In a randomized, blinded virtual Objective Structured Clinical Examination (OSCE) study, AMIE was compared to 21 primary care physicians (PCPs) across 100 multi-visit case scenarios designed to reflect UK NICE Guidance and BMJ Best Practice guidelines. AMIE was non-inferior to PCPs in management reasoning as assessed by specialists and scored better in both preciseness of treatments and investigations, and in its alignment with and grounding in clinical guidelines. To benchmark medication reasoning, we developed RxQA, a multiple-choice question benchmark derived from two national drug formularies (US, UK) and validated by board-certified pharmacists. Though AMIE and PCPs both benefited from the ability to access external drug information, AMIE outperformed PCPs on higher difficulty questions. While further research would be needed before real-world translation, AMIE’s strong performance across evaluations marks a significant step towards conversational AI as a tool in disease management.